Cowen Prime Advisors’s BioLife Solutions BLFS Stock Holding History

Cowen Prime Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,500	Closed	-$72K	–	173
2020 Q3	$72K	Buy	+2,500	New	+$54K	0.04%	107
2020 Q2	–	Sell	-6,173	Closed	-$59K	–	181
2020 Q1	$59K	Buy	+6,173	New	+$84.8K	0.04%	107
2019 Q2	–	Sell	-3,500	Closed	-$63K	–	173
2019 Q1	$63K	Buy	+3,500	New	+$55.7K	0.03%	108

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Cowen Prime Advisors's BLFS Position: Q4 2020 in Review

Cowen Prime Advisors sold out of BioLife Solutions (BLFS) in Q4 2020, closing a stake of 2,500 shares — an estimated $72K sold.

Cowen Prime Advisors first reported a position in BLFS in Q1 2019 and held it in 3 quarters. The position peaked at $72K in Q3 2020. 128 funds tracked by Wall St. Rank hold BLFS as of Q4 2020.

Cowen Prime Advisors reported no remaining BioLife Solutions position as of Q4 2020 after selling out during the quarter.
Cowen Prime Advisors sold 2,500 BioLife Solutions shares in Q4 2020, an estimated $72K.
Cowen Prime Advisors first reported a position in BioLife Solutions in Q1 2019 and held it in 3 quarters.
Cowen Prime Advisors's BioLife Solutions position peaked at $72K in Q3 2020.
128 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2020.

Based on Cowen Prime Advisors's 13F filing for Q4 2020, filed 27 Jan 2021.